Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

Rights & Permissions Free Resources Display this book on your site! Related Titles Adverse Events Associated with Childhood Vaccines:Evidence Bearing on Casuality Considerations for Viral Disease Eradication:Lessons Learned and Future Strategies: Workshop Summary Other Related Titles Options for Poliomyelitis Vaccination in the United States: Workshop Summary (1996) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "WORKSHOP AGENDA." Options for Poliomyelitis Vaccination in the United States: Workshop Summary. Washington, DC: The National Academies Press, 1996. Please select a format: Page 36   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Workshop Agenda INSTITUTE OF MEDICINE VACCINE SAFETY FORUM Workshop on Poliomyelitis Vaccines Savoy Suites Georgetown 2505 Wisconsin Avenue, N.W. Washington, D.C. Wednesday, June 7, 1995 7:30 a.m. Registration desk opens 8:15 Setting the Stage: Alternatives for U.S. Policy on Polio Vaccines Richard B. Johnston, Jr., Chair, IOM Vaccine Safety Forum and Chair of Wednesday morning session History and Current Status of Poliomyelitis Vaccines 8:30 General Overview, 1900–1995 Frederick C. Robbins, Case Western Reserve University 8:50 Current U.S. Status Walter Orenstein, Centers for Disease Control and Prevention 9:15 Other American Experience Ciro de Quadros, Pan American Health Organization Ronald Gold, Hospital for Sick Children, Toronto 9:45 Global Experience Stephen Cochi, Centers for Disease Control and Prevention Poliomyelitis Vaccine Characteristics 10:45 Current Status of OPV Peter Paradiso, Lederle-Praxis Biologicals Page 36 FRONT MATTER (R1-R6) CONTENTS (R7-R8) INTRODUCTION (1-2) HISTORY AND CURRENT STATUS (3-13) OPTIONS FOR POLIOMYELITIS VACCINATION (14-30) AFTERWORD (31-32) REFERENCES (33-34) ABBREVIATIONS (35-35) WORKSHOP AGENDA (36-39) WORKSHOP SPEAKERS (40-42)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 36
Options for Poliomyelitis Vaccination in the United States: Workshop Summary Workshop Agenda INSTITUTE OF MEDICINE VACCINE SAFETY FORUM Workshop on Poliomyelitis Vaccines Savoy Suites Georgetown 2505 Wisconsin Avenue, N.W. Washington, D.C. Wednesday, June 7, 1995 7:30 a.m. Registration desk opens 8:15 Setting the Stage: Alternatives for U.S. Policy on Polio Vaccines Richard B. Johnston, Jr., Chair, IOM Vaccine Safety Forum and Chair of Wednesday morning session History and Current Status of Poliomyelitis Vaccines 8:30 General Overview, 1900–1995 Frederick C. Robbins, Case Western Reserve University 8:50 Current U.S. Status Walter Orenstein, Centers for Disease Control and Prevention 9:15 Other American Experience Ciro de Quadros, Pan American Health Organization Ronald Gold, Hospital for Sick Children, Toronto 9:45 Global Experience Stephen Cochi, Centers for Disease Control and Prevention Poliomyelitis Vaccine Characteristics 10:45 Current Status of OPV Peter Paradiso, Lederle-Praxis Biologicals

OCR for page 37
Options for Poliomyelitis Vaccination in the United States: Workshop Summary 11:15 Current Status of IPV Carlton Meschievitz, Pasteur Mérieux Connaught 12:15 p.m. LUNCH Options for Poliomyelitis Vaccination   Chair, Wednesday afternoon session Russell Alexander, Seattle-King County Health Department 1:15 p.m. Benefits and Risks: Personal Experiences March of Dimes Historical Video John Salamone, Oakton, Virginia Lenita Schafer, Princeton, Massachusetts 1:40 Oral Poliovirus Vaccine—Benefits, Risks, and What Is Not Known Peter Wright, Vanderbilt University 2:20 Inactivated Poliovirus Vaccines—Benefits, Risks, and What Is Not Known Stanley Plotkin, Pasteur Mérieux Connaught 3:00 Sequential Use of IPV and OPV—Benefits, Risks, and What Is Not Known John Modlin, Dartmouth Medical School 3:50 Parental Choice—Benefits, Risks, and What Is Not Known Neal Halsey, Johns Hopkins University 4:00 No Vaccine—Benefits, Risks, and What Is Not Known D. A. Henderson, Johns Hopkins University 4:20 Modelling the Five Options Robert Kohberger, Lederle-Praxis Roland Sutter, Centers for Disease Control and Prevention 5:30 ADJOURN

OCR for page 38
Options for Poliomyelitis Vaccination in the United States: Workshop Summary CENTERS FOR DISEASE CONTROL AND PREVENTION Workshop on Poliomyelitis Vaccines Savoy Suites Georgetown 2505 Wisconsin Avenue, N.W. Washington, D.C. Thursday, June 8, 1995 8:30 a.m. Introduction and Charge for the Day Jeffrey Davis, Chair, Advisory Committee on Immunization Practices and Chair, Thursday session Implementation Issues for Poliomyelitis Vaccination 8:40 Potential Schedules Integrated into Harmonized Vaccination—Present and Future Jacqueline Gindler, Centers for Disease Control and Prevention 9:00 Future Prospects with Combination Vaccines Kathryn Edwards, Vanderbilt University 9:20 Provider Perspectives, Public and Private Guthrie Birkhead, New York State Department of Health Richard Zimmerman, University of Pittsburgh Caroline Hall, University of Rochester 9:50 Parent Perspectives Kathi Williams, National Vaccine Information Center 10:00 Consumer and Ethical Issues Lawrence Gostin, Georgetown University Law Center and Johns Hopkins University 10:20 Liability and Compensation Issues Robert Weibel, Vaccine Injury Compensation Program John Brydon, Attorney, Long Beach, California 11:00 Cost-Benefit Assessment of the Options Mark Miller, Centers for Disease Control and Prevention

OCR for page 39
Options for Poliomyelitis Vaccination in the United States: Workshop Summary 11:30 Discussion 12:15 p.m. LUNCH Considering the Options for Poliomyelitis Vaccination 1:45 p.m. Panel Summation Presentations OPV Only D. A. Henderson, Johns Hopkins University IPV Only Ronald Gold, Hospital for Sick Children, Toronto IPV-OPV Sequential Schedule Joseph Melnick, Baylor College of Medicine Informed Parental Choice Jessica Scheer, National Rehabilitation Hospital Research Center, Washington, D.C. No Vaccine Stephen C. Marini, Pennsylvania College of Chiropractic 2:20 Discussion 2:45 BREAK Discussion and Summary 3:00 Discussion of Unanswered Questions Jeffrey Davis, Chair, Advisory Committee on Immunization Practices 4:00 Summary of Workshop Presentations and Discussion Samuel Katz, Duke University 4:20 Discussion 5:00 ADJOURN

Representative terms from entire chapter:

vaccine safety